Literature DB >> 34619302

Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 3. On medical care and treatment of injuries from sulfur mustard.

Christopher M Timperley1, Jonathan E Forman2, Mohammad Abdollahi3, Abdullah Saeed Al-Amri4, Augustin Baulig5, Djafer Benachour6, Veronica Borrett7, Flerida A Cariño8, Christophe Curty9, Michael Geist10, David Gonzalez11, William Kane12, Zrinka Kovarik13, Roberto Martínez-Álvarez14, Nicia Maria Fusaro Mourão15, Slawomir Neffe16, Syed K Raza17, Valentin Rubaylo18, Alejandra Graciela Suárez19, Koji Takeuchi20, Cheng Tang21, Ferruccio Trifirò22, Francois Mauritz van Straten23, Paula S Vanninen24, Slavica Vučinić25, Volodymyr Zaitsev26, Muhammad Zafar-Uz-Zaman27, Mongia Saïd Zina28, Stian Holen29, Wesam S Alwan30, Vivek Suri31, Peter J Hotchkiss32, Mostafa Ghanei33.   

Abstract

Blister agents damage the skin, eyes, mucous membranes and subcutaneous tissues. Other toxic effects may occur after absorption. The response of the Scientific Advisory Board (SAB) of the Organisation for the Prohibition of Chemical Weapons (OPCW) to a request from the OPCW Director-General in 2013 on the status of medical countermeasures and treatments to blister agents is updated through the incorporation of the latest information. The physical and toxicological properties of sulfur mustard and clinical effects and treatments are summarised. The information should assist medics and emergency responders who may be unfamiliar with the toxidrome of sulfur mustard and its treatment. Crown
Copyright © 2021. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blister agent; Chemical warfare agent; Chemical weapons; Medical management; OPCW; Sulfur mustard

Mesh:

Substances:

Year:  2021        PMID: 34619302     DOI: 10.1016/j.tox.2021.152967

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  3 in total

1.  Supporting discovery and development of medical countermeasures for chemical injury to eye and skin.

Authors:  Houmam Araj; Hung Tseng; David T Yeung
Journal:  Exp Eye Res       Date:  2022-06-15       Impact factor: 3.770

2.  Retrospective detection for V-type OPNAs exposure via phosphonylation and disulfide adducts in albumin.

Authors:  Jin Wang; Fengjuan Sun; Xiaogang Lu; Runli Gao; Chengxin Pei; Hongmei Wang
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

Review 3.  Advice from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons on riot control agents in connection to the Chemical Weapons Convention.

Authors:  Christopher M Timperley; Jonathan E Forman; Pal Åas; Mohammad Abdollahi; Djafer Benachour; Abdullah Saeed Al-Amri; Augustin Baulig; Renate Becker-Arnold; Veronica Borrett; Flerida A Cariño; Christophe Curty; David Gonzalez; Michael Geist; William Kane; Zrinka Kovarik; Roberto Martínez-Álvarez; Robert Mikulak; Nicia Maria Fusaro Mourão; Slawomir Neffe; Evandro De Souza Nogueira; Ponnadurai Ramasami; Syed K Raza; Valentin Rubaylo; Ahmed E M Saeed; Koji Takeuchi; Cheng Tang; Ferruccio Trifirò; Francois Mauritz van Straten; Alejandra G Suárez; Farhat Waqar; Paula S Vanninen; Mohammad Zafar-Uz-Zaman; Slavica Vučinić; Volodymyr Zaitsev; Mongia Saïd Zina; Stian Holen; Fauzia Nurul Izzati
Journal:  RSC Adv       Date:  2018-12-19       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.